- Home
- OI vs SLNO Comparison
OI vs SLNO Comparison
Compare OI & SLNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | OI | SLNO |
|---|---|---|
| Founded | 1903 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Containers/Packaging | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 2.3B |
| IPO Year | 1994 | 2014 |
Fundamental Metrics
Financial Performance| Metric | OI | SLNO |
|---|---|---|
| Price | $10.65 | $34.16 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 11 |
| Target Price | $17.57 | ★ $108.00 |
| AVG Volume (30 Days) | ★ 2.1M | 1.3M |
| Earning Date | 05-13-2026 | 05-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 108.90 |
| EPS | N/A | ★ 0.39 |
| Revenue | ★ $6,426,000,000.00 | $1,450,788.00 |
| Revenue This Year | $3.07 | $155.44 |
| Revenue Next Year | $1.83 | $57.99 |
| P/E Ratio | ★ N/A | $94.31 |
| Revenue Growth | N/A | ★ 138.82 |
| 52 Week Low | $9.23 | $32.63 |
| 52 Week High | $16.91 | $89.12 |
Technical Indicators
Market Signals| Indicator | OI | SLNO |
|---|---|---|
| Relative Strength Index (RSI) | 22.74 | 32.76 |
| Support Level | N/A | $32.63 |
| Resistance Level | $13.54 | $44.60 |
| Average True Range (ATR) | 0.62 | 2.45 |
| MACD | -0.23 | -0.18 |
| Stochastic Oscillator | 1.70 | 14.19 |
Price Performance
Historical ComparisonAbout OI O-I Glass Inc.
O-I Glass is the world's largest manufacturer of glass bottles; 70% of its revenue comes from outside the United States. O-I has a leading position in key markets such as Europe, North America, and Brazil. Beer is the primary end market for O-I's glass bottles, which are also used for wine, soda, spirits, condiments, and food. O-I is looking to maintain or expand its dominant positions in Europe, North America, and South America.
About SLNO Soleno Therapeutics Inc.
Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.